NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/20/2022
Back to search
Official data from USPTO
SYMPHOGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYMPHOGEN
ST13
US500000079075883Class
1, 5, 42, 45
Filing
79075883
Registration
3882672
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
06/20/2022
Trademark type
Word
Nice classes
1, 5, 42, 45
Filing date
10/02/2009
Registration date
11/30/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2021
Last transaction
03/02/2021
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DK
Examiner
YARD, JOHN S
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Symphogen A/S
S. A. (pessoa física)
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industryscience and photography; biochemicalshuman and animalmonoclonal and polyclonal antibodies for in-vivo or in-vitro scientific research and developmentincluding scientific research into diseasesin particular cancerAIDS (acquired immune deficiency syndrome) and other infectious diseasesimmune and auto-immune diseasesinflammatory diseases and cardiovascular diseases
Class 5
Pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cancerAIDS (Acquired Immune Deficiency Syndrome) and other infectious diseasesimmune and auto-immune diseasesinflammatory diseases and cardiovascular diseasesIdiopathic Thrombocytopenic Purpura (ITP)Hemolytic Disease of Newborns (HDN)smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseaseshematological diseasesrespiratory diseases; veterinary preparations for cancerAIDS (Acquired Immune Deficiency Syndrome) and other infectious diseasesimmune and auto-immune diseasesinflammatory diseases and cardiovascular diseasessmallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseaseshematological diseases; pharmaceutical preparations based on antibodiesincluding humananimalmonoclonal and polyclonal antibodies for the treatment of cancerAIDS (Acquired Immune Deficiency Syndrome) and other infectious diseasesimmune and auto-immune diseasesinflammatory diseases and cardiovascular diseasesIndiopathic Thrombocytopenic Purpura (ITP)Hemolytic Disease of Newborns (HDN) smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseasesHematological diseases and respiratory diseases; dietetic foods adapted for medical use
Class 42
Research in the field of medical scienceincluding biological research and in particular research into antibodiesincluding humananimalmonoclonal and polyclonal antibodies and the development of medicines based on antibodiesincluding humananimalmonoclonal and polyclonal antibodies; chemical analyses; computer programmingcomputer programming for the gathering and processing of medical data in connection with medical science researchdevelopment and therapyincluding research intodevelopment oftherapy using antibodiesincluding humananimalmonoclonal and polyclonal antibodies
Class 45
Patent licensing; Patent and industrial property consultation; licensing of industrial property within medical science
Publications
History of USPTO decisions and trademark events.
58 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/11/2022
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/23/2022
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/12/2022
INPC
INVALIDATION PROCESSED
03/12/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/02/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/02/2021
71AG
REGISTERED-SEC.71 ACCEPTED
03/02/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/02/2021
ES71
TEAS SECTION 71 RECEIVED
11/16/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/30/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/30/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/30/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/30/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/30/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/30/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/23/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/30/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/17/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/08/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
01/11/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/01/2017
INPC
INVALIDATION PROCESSED
12/01/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/15/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/15/2017
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
03/15/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/15/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/09/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/02/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
10/03/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/18/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/31/2011
FIMP
FINAL DISPOSITION PROCESSED
03/31/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
11/30/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2010
PUBO
PUBLISHED FOR OPPOSITION
09/14/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/12/2010
ALIE
ASSIGNED TO LIE
08/12/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
07/27/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/27/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
07/27/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/27/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/30/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/30/2010
RFNP
REFUSAL PROCESSED BY IB
01/29/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/05/2010
RFRR
REFUSAL PROCESSED BY MPU
01/05/2010
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/02/2010
CNRT
NON-FINAL ACTION WRITTEN
01/01/2010
DOCK
ASSIGNED TO EXAMINER
12/30/2009
MAFR
APPLICATION FILING RECEIPT MAILED
12/26/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/22/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/17/2009
Continuous trademark protection
Get notified about every new filing that threatens SYMPHOGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.